Cystic fibrosis gene therapy regulatory update

FDA granted Orphan Drug designation to the non-viral DNA nanoparticles gene therapy to treat cystic fibrosis (CF). The therapy uses PLASmin non-viral gene transfer technology to deliver a normal copy ...